Grana CM - Search Results

1

Interim ¹⁸FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic review.

Ferrari M, Travaini LL, Ciardo D, Garibaldi C, Gilardi L, Glynne-Jones R, Grana CM, Jereczek-Fossa BA, Marvaso G, Ronchi S, Leonardi MC, Orecchia R, Cremonesi M. Ferrari M, et al. Among authors: grana cm. Crit Rev Oncol Hematol. 2017 May;113:28-42. doi: 10.1016/j.critrevonc.2017.02.019. Epub 2017 Feb 20. Crit Rev Oncol Hematol. 2017. PMID: 28427517 Review.

2

Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapy.

Paganelli G, Orecchia R, Jereczek-Fossa B, Grana C, Cremonesi M, De Braud F, Tradati N, Chinol M. Paganelli G, et al. Eur J Nucl Med. 1998 Sep;25(9):1336-9. doi: 10.1007/s002590050305. Eur J Nucl Med. 1998. PMID: 9724386

3

Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, Galimberti V, Calza P, Viale G, Veronesi U, Paganelli G. De Cicco C, et al. J Nucl Med. 1998 Dec;39(12):2080-4. J Nucl Med. 1998. PMID: 9867145 Free article.

4

Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.

Cremonesi M, Ferrari M, Chinol M, Stabin MG, Grana C, Prisco G, Robertson C, Tosi G, Paganelli G. Cremonesi M, et al. Eur J Nucl Med. 1999 Feb;26(2):110-20. doi: 10.1007/s002590050366. Eur J Nucl Med. 1999. PMID: 9933344 Clinical Trial.

5

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.

Paganelli G, Grana C, Chinol M, Cremonesi M, De Cicco C, De Braud F, Robertson C, Zurrida S, Casadio C, Zoboli S, Siccardi AG, Veronesi U. Paganelli G, et al. Eur J Nucl Med. 1999 Apr;26(4):348-57. doi: 10.1007/s002590050397. Eur J Nucl Med. 1999. PMID: 10199940 Clinical Trial.

6

Sentinel node biopsy in early vulvar cancer.

De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, Maggioni A, Bocciolone L, Mangioni C, Colombo N, Paganelli G. De Cicco C, et al. Br J Cancer. 2000 Jan;82(2):295-9. doi: 10.1054/bjoc.1999.0918. Br J Cancer. 2000. PMID: 10646880 Free PMC article.

7

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.

Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Mäcke HR, Chinol M, de Braud F. Paganelli G, et al. Eur J Nucl Med. 2001 Apr;28(4):426-34. doi: 10.1007/s002590100490. Eur J Nucl Med. 2001. PMID: 11357492 Clinical Trial.

8

Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results.

Paganelli G, Bartolomei M, Ferrari M, Cremonesi M, Broggi G, Maira G, Sturiale C, Grana C, Prisco G, Gatti M, Caliceti P, Chinol M. Paganelli G, et al. Cancer Biother Radiopharm. 2001 Jun;16(3):227-35. doi: 10.1089/10849780152389410. Cancer Biother Radiopharm. 2001. PMID: 11471487 Clinical Trial.

9

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study.

Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, Caracciolo M, Mäcke HR, Chinol M, Paganelli G. Bodei L, et al. Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):207-16. doi: 10.1007/s00259-002-1023-y. Epub 2002 Nov 16. Eur J Nucl Med Mol Imaging. 2003. PMID: 12552338 Clinical Trial.

10

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M, Lopera Sierra M, Cremonesi M, Chinol M, Mäcke HR, Paganelli G. Bodei L, et al. Cancer Biother Radiopharm. 2004 Feb;19(1):65-71. doi: 10.1089/108497804773391694. Cancer Biother Radiopharm. 2004. PMID: 15068613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page